merrimack pharmaceuticals in
(MACK:Consolidated Issue listed on NASDAQ Global Market)
Douglas A. Lauffenburger Ph.D.
Member of Scientific Advisory Board, Merrimack Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 67 board members in 6 different organizations across 8 different industries.|
See Board Relationships
Dr. Douglas A. Lauffenburger, Ph. D. (Doug) serves as Director of Biological Engineering Division of Massachusetts Institute of Technology (MIT) and its Co-Director of Bioengineering & Environmental Health. Dr. Lauffenburger serves as Consultant of Astra-Zeneca, CellPro, Entelos, Inc., Insert Therapeutics, Inc., Johnson & Johnson, Pfizer, SyStemix, the Burroughs-Wellcome Foundation and the Whitaker Foundation. He is Uncas & Helen Whitaker Professor of Bioengineering, ...
One Kendall SquarePhone: 617-441-1000
Cambridge, Massachusetts 02139
Board Members Memberships*
Member of the Scientific Advisory Board
University of Minnesota
University of Illinois-Urbana-Champaign
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|